Old Drugs, New Tricks: Remdesivir and Other Potential Treatments for COVID19

The video discusses Remdesivir, an antiviral drug developed by Gilead Sciences, initially for hepatitis C and Ebola. It shows potential against coronaviruses, including COVID-19, by targeting viral replication mechanisms. Various studies, including those by Gilead and NIAID, indicate it may reduce recovery time but not mortality rates. The drug is approved for emergency use in some countries, but more research is needed to confirm its efficacy and safety.

What new insight or understanding did you gain from this video?